Van Steenbergen W, Rigauts H, Ponette E, Peetermans W, Pelemans W, Fevery J
Department of Internal Medicine, UZ Gasthuisberg, K.U. Leuven, Belgium.
J Am Geriatr Soc. 1993 Feb;41(2):157-62. doi: 10.1111/j.1532-5415.1993.tb02051.x.
To assess the immediate and long-term outcomes of elderly patients with acute complicated cholecystitis treated by percutaneous cholecystostomy. To assess the results of bile cultures obtained in this group of patients.
Case series.
Tertiary care center.
Thirty-two patients, with a mean (+/- S.D.) age of 78 +/- 8 years (range, 58-92 years), and who presented with acute cholecystitis complicated by empyema formation. Sixty-six percent had associated disorders, which rendered them at high risk for surgical intervention.
Percutaneous transhepatic catheter drainage of the gallbladder, with a mean drainage time of 20 days (range 0-84 days). In addition, endoscopic sphincterotomy with removal of common bile duct stones was performed in six patients and percutaneous aspiration of an associated liver abscess in four cases.
Percutaneous cholecystostomy was followed by rapid regression of clinical symptoms and of radiologic abnormalities in all patients. Sixteen cases (50%) underwent elective cholecystectomy 1-12 weeks after cholecystostomy. One of them died of aspiration pneumonia, whereas 15 had no post-operative problems and were discharged 9 days (mean) after surgery. Forty-four percent (14/32) were considered inoperable: they remained completely free of biliary symptoms and died of unrelated illness (22%) after a mean follow-up of 6 months (range, 1-22 months) or are still alive (22%) with a mean follow-up of 15 months (range, 5-36 months). Bile cultures were positive in 75% of the patients. Escherichia coli, other aerobic Gram-negative micro-organisms, and anaerobic bacterial species accounted for 35% (16/46), 28% (13/46), and 20% (9/46) of the isolated bacteria, respectively. All aerobic Gram-negative species tested in vitro were susceptible to gentamicin and to temocillin.
Percutaneous transhepatic cholecystostomy is a safe and effective procedure in the treatment of elderly high-risk patients with acute cholecystitis complicated by empyema formation. It can be followed by elective cholecystectomy, if possible, or by expectant conservative management in patients who are inoperable because of systemic disease.
评估经皮胆囊造瘘术治疗老年急性复杂性胆囊炎的近期和远期疗效。评估该组患者胆汁培养的结果。
病例系列研究。
三级医疗中心。
32例患者,平均(±标准差)年龄为78±8岁(范围58 - 92岁),均表现为急性胆囊炎合并积脓形成。66%的患者有相关疾病,使其接受手术干预的风险较高。
经皮经肝胆囊置管引流,平均引流时间为20天(范围0 - 84天)。此外,6例患者进行了内镜括约肌切开取胆总管结石术,4例患者进行了经皮肝脓肿穿刺抽吸术。
经皮胆囊造瘘术后所有患者的临床症状和影像学异常均迅速缓解。16例(50%)患者在胆囊造瘘术后1 - 12周接受了择期胆囊切除术。其中1例死于吸入性肺炎,15例术后无问题,术后平均9天出院。44%(14/32)的患者被认为无法手术:他们完全没有胆道症状,在平均随访6个月(范围1 - 22个月)后死于无关疾病(22%),或在平均随访15个月(范围5 - 36个月)后仍存活(22%)。75%的患者胆汁培养呈阳性。大肠杆菌、其他需氧革兰氏阴性微生物和厌氧菌分别占分离细菌的35%(16/46)、28%(13/46)和20%(9/46)。所有体外测试的需氧革兰氏阴性菌对庆大霉素和替莫西林敏感。
经皮经肝胆囊造瘘术是治疗老年高危急性胆囊炎合并积脓形成患者的一种安全有效的方法。如果可能,后续可进行择期胆囊切除术,对于因全身疾病无法手术的患者可进行保守观察治疗。